A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer

Clinical Nutrition

Volumn 35, Issue 2, 2016, Pages 359-369

  Mocellin, Michel C ^a   Camargo, Carolina Q ^a   Nunes, Everson Araujo ^a   Fiates, Giovanna M R ^a   Trindade, Erasmo B S M ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Colorectal cancer; Inflammation; Inflammatory markers; Meta analysis; N 3 polyunsaturated fatty acids; Systematic review

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; ANTINEOPLASTIC AGENT; AUTACOID; C REACTIVE PROTEIN; CYTOKINE; DOCOSAHEXAENOIC ACID; FISH OIL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; OMEGA 3 FATTY ACID; PLACEBO; BIOLOGICAL MARKER; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 1BETA; SERUM ALBUMIN; TUMOR NECROSIS FACTOR;

ALBUMIN BLOOD LEVEL; ARTICLE; CANCER PATIENT; CANCER THERAPY; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; COLORECTAL SURGERY; DRUG DOSE INCREASE; ENTERAL DRUG ADMINISTRATION; HUMAN; INFLAMMATION; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUPPLEMENTATION; SURGICAL PATIENT; SYSTEMATIC REVIEW; TREATMENT DURATION; BLOOD; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENT; METABOLISM; REPRODUCIBILITY;

BIOMARKERS; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84960483416     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.04.013     Document Type: Article

References (44)

1. Crawford S. Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence. Ther Adv Med Oncol 2014, 6(2):52-68.
2. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140(6):883-899.
3. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420(6917):860-867.
4. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357(9255):539-545.
5. Elinav E., Nowarski R., Thaiss C.A., Hu B., Jin C., Flavell R.A. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013, 13(11):759-771.
6. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454(7203):436-444.
7. Moore M.M., Chua W., Charles K.A., Clarke S.J. Inflammation and cancer: causes and consequences. Clin Pharmacol Ther 2010, 87(4):504-508.
8. Merendino N., Costantini L., Manzi L., Molinari R., D'Eliseo D., Velotti F. Dietary omega -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer. Biomed Res Int 2013, 2013:310186.
9. Vaughan V.C., Hassing M.R., Lewandowski P.A. Marine polyunsaturated fatty acids and cancer therapy. Br J Cancer 2013, 108(3):486-492.
10. Murphy R.A., Mourtzakis M., Mazurak V.C. n-3 polyunsaturated fatty acids: the potential role for supplementation in cancer. Curr Opin Clin Nutr Metabolic Care 2012, 15(3):246-251.
11. Murphy R.A., Yeung E., Mazurak V.C., Mourtzakis M. Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer 2011, 105(10):1469-1473.
12. Cockbain A.J., Toogood G.J., Hull M.A. Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 2012, 61(1):135-149.
13. Calder P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. Br J Clin Pharmacol 2013, 75(3):645-662.
14. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8(5):349-361.
15. Buckley C.D., Gilroy D.W., Serhan C.N. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 2014, 40(3):315-327.
16. Xin W., Wei W., Li X. Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 2012, 12:77.
17. Myhrstad M.C., Retterstol K., Telle-Hansen V.H., Ottestad I., Halvorsen B., Holven K.B., et al. Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors. Inflamm Res Official J Eur Histamine Res Soc 2011, 60(4):309-319.
18. Rangel-Huerta O.D., Aguilera C.M., Mesa M.D., Gil A. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Brit J Nut 2012, 107(Suppl. 2):S159-S170.
19. WHO Cancer 2014, [updated 03/29/2014], Available from:. http://www.who.int/mediacentre/factsheets/fs297/en/.
20. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Internal Med 2009, 151(4):W65-W94.
21. Corrêa C., Angeleli A., Camargo N., L B., RC B. Comparison of PCR/albumin ratio with prognostic inflammatory nutritional index (PINI). J Brasileiro Patol Med Labor 2002, 38(3):7.
22. JPT GSe Higgins Cochrane handbook for systematic reviews of interventions 2011, Available from:. http://www.cochrane-handbook.org.
23. Moher D., Hopewell S., Schulz K.F., Montori V., Gotzsche P.C., Devereaux P.J., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials 2010, 340. BMJ (Clinical research ed), c869.
24. Purasiri P., Murray A., Richardson S., Heys S.D., Horrobin D., Eremin O. Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin Sci London England 1979 1994, 87(6):711-717.
25. White I.R., Thomas J. Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis. Clin Trials 2005, 2(2):141-151.
26. Braga M., Gianotti L., Vignali A., Carlo V.D. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002, 132(5):805-814.
27. Sorensen L.S., Thorlacius-Ussing O., Schmidt E.B., Rasmussen H.H., Lundbye-Christensen S., Calder P.C., et al. Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery. Brit J Surg 2014, 101(2):33-42.
28. Trabal J., Leyes P., Forga M., Maurel J. Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutricion Hospitalaria 2010, 25(5):736-740.
29. Liang B., Wang S., Ye Y.J., Yang X.D., Wang Y.L., Qu J., et al. Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol WJG 2008, 14(15):2434-2439.
30. Zhu M.W., Tang D.N., Hou J., Wei J.M., Hua B., Sun J.H., et al. Impact of fish oil enriched total parenteral nutrition on elderly patients after colorectal cancer surgery. Chinese Med J 2012, 125(2):178-181.
31. Horie H., Okada M., Kojima M., Nagai H. Favorable effects of preoperative enteral immunonutrition on a surgical site infection in patients with colorectal cancer without malnutrition. Surg Today 2006, 36(12):1063-1068.
32. Mocellin M.C., Pastore e Silva JdA., Camargo CdQ., de Souza Fabre M.E., Gevaerd S., Naliwaiko K., et al. Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients. Lipids 2013, 48(9):879-888.
33. Pastore Silva JdA., Santos de Moraes Trindade EB., de Souza Fabre M.E., Menegotto V.M., Gevaerd S., Buss ZdS., et al. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nut Cancer Int J 2012, 64(2):267-273.
34. Pierre J.F., Heneghan A.F., Lawson C.M., Wischmeyer P.E., Kozar R.A., Kudsk K.A. Pharmaconutrition review: physiological mechanisms. JPEN J Parenteral Enteral Nut 2013, 37(5 Suppl.):51S-65S.
35. Kimura Y., Kono S., Toyomura K., Nagano J., Mizoue T., Moore M.A., et al. Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: the fukuoka colorectal cancer study. Cancer Sci 2007, 98(4):590-597.
36. Norat T., Bingham S., Ferrari P., Slimani N., Jenab M., Mazuir M., et al. Meat, fish, and colorectal cancer risk: the european prospective investigation into cancer and nutrition. J Natl Cancer Inst 2005, 97(12):906-916.
37. Hall M.N., Chavarro J.E., Lee I.M., Willett W.C., Ma J.A. 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev Pub Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 2008, 17(5):1136-1143.
38. Ferrandez A., Prescott S., Burt R.W. COX-2 and colorectal cancer. Curr Pharm Des 2003, 9(27):2229-2251.
39. Soumaoro L.T., Iida S., Uetake H., Ishiguro M., Takagi Y., Higuchi T., et al. Expression of 5-lipoxygenase in human colorectal cancer. World J Gastroenterol WJG 2006, 12(39):6355-6360.
40. Landskron G., De la Fuente M., Thuwajit P., Thuwajit C., Hermoso M.A. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014, 2014:149185.
41. Vermeire S., Van Assche G., Rutgeerts P. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Prac Gastroenterol Hepatol 2005, 2(12):580-586.
42. Kwon K.A., Kim S.H., Oh S.Y., Lee S., Han J.Y., Kim K.H., et al. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 2010, 10:203.
43. Chachkhiani I., Gurlich R., Maruna P., Frasko R., Lindner J. The postoperative stress response and its reflection in cytokine network and leptin plasma levels. Physiol Res Acad Sci Bohemos 2005, 54(3):279-285.
44. Furukawa K., Tashiro T., Yamamori H., Takagi K., Morishima Y., Sugiura T., et al. Effects of soybean oil emulsion and eicosapentaenoic acid on stress response and immune function after a severely stressful operation. Annals Surg 1999, 229(2):255-261.